Drug Information

General Information
Drug ID
DR00208
Drug Name
Estradiol-17beta-glucuronide
Synonyms
[3H]-estradiol-17beta-glucuronide
Drug Type
Small molecular drug
Indication Discovery agent [ICD11: N.A.] Investigative
Structure
3D MOL 2D MOL
Formula
C24H32O8
Canonical SMILES
CC12CCC3C(C1CCC2OC4C(C(C(C(O4)C(=O)O)O)O)O)CCC5=C3C=CC(=C5)O
InChI
InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(25)10-11(13)2-4-15(14)16(24)6-7-17(24)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1
InChIKey
MTKNDAQYHASLID-QXYWQCSFSA-N
Pharmaceutical Properties Molecular Weight 448.5 Topological Polar Surface Area 137
Heavy Atom Count 32 Rotatable Bond Count 3
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 8
XLogP
2.7
PubChem CID
5281887
ChEBI ID
ChEBI:791
TTD Drug ID
D0I3LQ
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [1]
MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
MRP3 Transporter Info Multidrug resistance-associated protein 3 Substrate [3]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [4]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [5]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [6]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [7]
OATP1C1 Transporter Info Organic anion transporting polypeptide 1C1 Substrate [8]
Drug-Transporter Activity Data
Drug-Transporter Activity Data BCRP Transporter Info Km = 44.2 microM Human embryonic kidney cells (HEK293)-BCRP [9]
MRP1 Transporter Info Km = 1.5 microM Human cervical cancer cell line (Hela)-MRP1 [10]
MRP1 Transporter Info Km = 2.5 microM Human cervical cancer cell line (Hela)-MRP1 [11]
MRP1 Transporter Info Km = 1.5 microM Human embryonic kidney cells (HEK293)-MRP1 [2]
MRP2 Transporter Info Km = 7.2 microM Human embryonic kidney cells (HEK293)-MRP2 [2]
MRP3 Transporter Info Km = 25.6 microM Human embryonic kidney cells (HEK293)-MRP3 [12]
MRP3 Transporter Info Km = 29 microM Human embryonic kidney cells (HEK293)-MRP3 [3]
MRP3 Transporter Info Km = 17.7 microM Spodoptera frugiperda (Sf9) cells-MRP3 [13]
MRP4 Transporter Info Km = 30.3 microM Spodoptera frugiperda (Sf9) cells-MRP4 [14]
OATP1B1 Transporter Info Km = 5.4 microM Chinese hamster ovary (CHO) cells-OATP1B1 [15]
OATP1B1 Transporter Info Km = 5.9 microM Chinese hamster ovary (CHO) cells-OATP1B1 [6]
OATP1B1 Transporter Info Km = 2.5 microM Human embryonic kidney cells (HEK293)-OATP1B1 [16]
OATP1B1 Transporter Info Km = 8.29 microM Human embryonic kidney cells (HEK293)-OATP1B1 [17]
OATP1B3 Transporter Info Km = 15.8 microM Chinese hamster ovary (CHO) cells-OATP1B3 [15]
OATP1B3 Transporter Info Km = 24.6 microM Human embryonic kidney cells (HEK293)-OATP1B3 [17]
References
1 Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites. Drug Metab Dispos. 2014 Apr;42(4):575-85.
2 Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol. 1999 May;55(5):929-37.
3 Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry. 2003 Aug 26;42(33):9989-10000.
4 Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 2007 Feb;453(5):661-73.
5 Regulation of renal oatp mRNA expression by testosterone. Am J Physiol. 1996 Feb;270(2 Pt 2):F332-7.
6 Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17beta-glucuronide transport. Pharmacol Res. 2009 Jul;60(1):50-6.
7 Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos. 2011 May;39(5):920-6.
8 The blood-brain barrier thyroxine transporter organic anion-transporting polypeptide 1c1 displays atypical transport kinetics. Endocrinology. 2009 Nov;150(11):5153-62.
9 Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 2003 Jul 15;63(14):4048-54.
10 Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 1996 Mar 1;56(5):988-94.
11 ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem. 1996 Apr 19;271(16):9683-9.
12 Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 2000 Sep 1;60(17):4779-84.
13 Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem. 2001 Dec 7;276(49):46400-7.
14 Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem. 2001 Sep 7;276(36):33747-54.
15 Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur J Pharmacol. 2008 Apr 14;584(1):57-65.
16 Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica. 2005 Jul;35(7):737-53.
17 Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther. 2004 Oct;311(1):139-46.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.